Roper Technologies ROP
Roper Technologies is a technology conglomerate that designs and sells software and engineered products for niche markets. Roper Technologies shows exceptional earnings growth (233%) and an attractive valuation (P/E 14.95, FCF yield 6.39%), although its financial health is weighed down by high leverage (ND/EBITDA 3.38) and negative momentum (12-1: -13.89%).
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Roper Technologies is a technology conglomerate that designs and sells software and engineered products for niche markets. Roper Technologies shows exceptional earnings growth (233%) and an attractive valuation (P/E 14.95, FCF yield 6.39%), although its financial health is weighed down by high leverage (ND/EBITDA 3.38) and negative momentum (12-1: -13.89%).
Score by category
| Category | Score |
|---|---|
| Financial health | 4.4 |
| Quality / Moat | 6.3 |
| Valuation | 7.1 |
| Growth | 8.2 |
| Dividend | 4.2 |
| Momentum | 4.1 |
| Risk & Context | 7.5 |
OVERALL SCORE: 6.5/10
Context and risks
No relevant news or specific regulatory, geopolitical, or business model exposure that is not already captured by the quantitative metrics. The country's governance risk (US) is moderate and already reflected in the reference data.
News considered in the analysis
- Roche Holding (SWX:ROP) Signed New AI Drug Discovery Partnerships — Noticia sobre Roche Holding (ticker SWX:ROP), no sobre Roper Technologies (NASDAQ:ROP). Sin relevancia.
- 4 Dividend Rules That Keep Retirees From Buying a Payout That Gets Cut — Listículo genérico sobre reglas de dividendos, sin información específica sobre Roper Technologies.
- 3 Industrial Stocks You’ve Never Heard of With 25+ Years of Dividend Increases — Listículo genérico; no menciona a Roper Technologies.
- Roche (SWX:ROP) Stock Looks Discounted As Its 60% Run Continues — Noticia sobre Roche Holding (ticker SWX:ROP), no sobre Roper Technologies (NASDAQ:ROP). Sin relevancia.
- Is Roche Holding (SWX:ROP) Undervalued Following Its Phase 3 IgA Nephropathy Win? — Noticia sobre Roche Holding (ticker SWX:ROP), no sobre Roper Technologies (NASDAQ:ROP). Sin relevancia.
Verdict: Hold; the combination of strong growth and reasonable valuation is positive, but high leverage and weak momentum warrant caution before adding positions.
Main risk: The high leverage (Net Debt/EBITDA of 3.38) is the main financial risk, especially if the interest rate environment remains high or worsens, making debt service more expensive.
Other Technology companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →